ImmuneBiotech welcomes Sara Malcus as Chairman of the Board

ImmuneBiotech AB

ImmuneBiotech is delighted to announce the appointment of Dr. Sara Malcus as Chairman of the Board of Directors.

Dr. Malcus (former CEO at MetaboGen) brings many years of experience from executive positions in both food and drug developing companies. Her deep understanding of the microbiome field aligns with ImmuneBiotech’s mission and will be valuable in shaping the company’s strategic direction and future growth.

This appointment further underscores ImmuneBiotech´s seamless commitment to expanding and enhancing our presence in the probiotics and microbiome sector through continuous innovation.

 

Welcome on board!!

Full PR: Link